Agenus director granted 105,000 stock options
AGENUS INC director Susan B. Hirsch received a grant of stock options to acquire 105,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
AGENUS INC director Susan B. Hirsch received a grant of stock options to acquire 105,000 shares of Common Stock. The options have an exercise price of $3.90 per share and were awarded at no cost as a compensation grant.
The award was granted under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan and will vest on the one-year anniversary of the grant date. Following this grant, Hirsch holds stock options covering 105,000 underlying shares directly, with an expiration date in 2036.
Insider Trade Summary
Grant/Award: 105,000 shares
Grant/Award
1 txn
Insider
Hirsch Susan B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 105,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 105,000 contracts (Direct)
Footnotes (1)
- F1. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date.
Key Figures
Stock options granted: 105,000 options
Exercise price: $3.90 per share
Underlying shares: 105,000 shares
+2 more
5 metrics
Stock options granted
105,000 options
Grant to director Susan B. Hirsch on April 24, 2026
Exercise price
$3.90 per share
Exercise price for Agenus Common Stock under the option
Underlying shares
105,000 shares
Common Stock underlying the stock option award
Total options after grant
105,000 options
Total derivative securities following the reported transaction
Expiration date
April 24, 2036
Expiration of stock option award to Susan B. Hirsch
Key Terms
Stock Option, exercise price, Equity Incentive Plan, expiration date
4 terms
Stock Option financial
"security_title": "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "3.9000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Equity Incentive Plan financial
"Agenus Inc. 2019 Amended and Restated Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
expiration date financial
"expiration_date": "2036-04-24T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Agenus (AGEN) director Susan B. Hirsch receive in this Form 4 filing?
Susan B. Hirsch received a grant of stock options covering 105,000 shares of Agenus Common Stock. These options were awarded as compensation, allowing her to purchase shares at a fixed exercise price if the options vest and are exercised.
What is the exercise price and size of the new Agenus (AGEN) stock option grant?
The grant gives Susan B. Hirsch options on 105,000 underlying Agenus Common shares at an exercise price of $3.90 per share. She pays nothing for the grant itself, but must pay the exercise price to acquire shares in the future.
When do Susan B. Hirsch’s Agenus (AGEN) stock options vest and expire?
The options vest on the one-year anniversary of the April 24, 2026 grant date. They carry an expiration date of April 24, 2036, giving a ten-year window after grant to exercise once vested, subject to applicable plan and agreement terms.
Under which plan were the Agenus (AGEN) stock options to Susan B. Hirsch granted?
The stock options were awarded under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan. This plan governs equity-based compensation for eligible participants, including terms for vesting, exercise, and expiration of option awards granted by the company.
How many Agenus (AGEN) stock options does Susan B. Hirsch hold after this transaction?
After this transaction, Susan B. Hirsch holds stock options covering 105,000 underlying Agenus Common shares directly. This entire position comes from the newly granted options reported, as indicated by the total shares following the transaction field in the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates